2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 5
As coordinator: 1
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0.25*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 10.379.596 | 819.158 | 2 | ||
2019 | 0 | 5.982.255 | 1.111.540 | 1 | ||
2013 | 0 | 3.036.614 | 378.437 | 1 | ||
2011 | 1.410.405 | 0 | 498.425 | 1 |
Total number of partners: 35
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 35
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-02-01 | A Personalised Living Cell Synthetic Computing Circuit for Sensing and Treating Neurodegenerative Disorders | PRIME | participant | 4.401.253 | 7 |
2021-01-01 | Edge AI-deployed DIGItal Twins for PREDICTing disease progression and need for early intervention in infectious and cardiovascular diseases beyond COVID-19 | DIGIPREDICT | participant | 5.978.344 | 10 |
2019-01-01 | Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces | GLADIATOR | participant | 5.982.255 | 7 |
2013-10-01 | "Innovative, mechanistic-based strategies for delivery of therapeutic macromolecules across cellular and biological barriers" | PATHCHOOSER | participant | 3.036.614 | 9 |
2011-11-01 | Management of Resistance to Tyrosine Kinase Inhibitors with Advanced Nanosystems | NANORESISTANCE | coordinator | 1.410.405 | 7 |